期刊
ANNUAL REVIEW OF MEDICINE
卷 60, 期 -, 页码 153-165出版社
ANNUAL REVIEWS
DOI: 10.1146/annurev.med.60.061107.145152
关键词
prognostic profiling; genetic polymorphism; epigenetics; micrometastases
The genomic era has been characterized by an exponential increase in the number of targets in the management of breast cancer. Prognostic profiling has helped to determine which tumors are more likely to be associated with poor disease-free survival. Gene expression profiles are being studied in order to improve predictions of response and toxicity. Epigenetics is being evaluated for its ability to influence estrogen receptor expression. However, these fields require further validation. This review discusses the advances in the management of breast cancer through genomic evaluation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据